U2BIO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,900 KRW | -1.27% |
|
-8.34% | -26.14% |
| 2023 | U2Bio Co., Ltd. has filed an IPO. | CI |
| 2020 | Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion. | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 4,675.00 | 5,710.00 | 6,250.00 |
| Spread/Res. | -16.58% | -31.70% | -37.60% |
| Spread/Supp. | +4.28% | +4.28% | +3.59% |
| Support | 3,740.00 | 3,740.00 | 3,765.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- A221800 Stock
- Charts U2Bio Co., Ltd.
